Skip to main content

Table 1 Relationship between miR-638 expression and their clinic-pathological characteristics of breast cancer patients

From: MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway

Characteristics Cases miR-638 P value
High Low
Age (years)     0.11
 ≥ 50 27 12 15  
 < 50 25 10 15  
Tumor size     0.022*
 < 3 cm 35 11 24  
 ≥ 3 cm 17 5 12  
ER status     0.256
 Negative 22 8 14  
 Positive 30 13 17  
PR status     0.119
 Negative 24 10 14  
 Positive 28 13 15  
HER2 status     0.391
 Negative 32 14 18  
 Positive 20 7 13  
Lymph node metastasis     0.004*
 Yes 37 12 25  
 No 15 5 10  
TNM stage     0.049*
 I-II 14 6 8  
 III-IV 38 15 23  
  1. Statistical analyses were performed by the χ2 test
  2. *P < 0.05 was considered significant